| DFTX | Definium Therapeutics Inc Ordinary Shares | 3.09% |
| MBX | MBX Biosciences Inc | 2.72% |
| ALMS | Alumis Inc | 2.14% |
| ATAI | AtaiBeckley Inc | 2.13% |
| TRVI | Trevi Therapeutics Inc | 2.12% |
| ELVN | Enliven Therapeutics Inc | 2.09% |
| AMLX | Amylyx Pharmaceuticals Inc | 2.04% |
| MANE | Veradermics Inc | 2.02% |
| LGND | Ligand Pharmaceuticals Inc | 1.94% |
| NUVB | Nuvation Bio Inc Ordinary Shares - Class A | 1.89% |
No recent news for XPH. The ingest cron pulls every 15 minutes during market hours.
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index"). Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. Allows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
State Street SPDR S&P Pharmaceuticals ETF · Issued by SPDR